iBio, Inc.
IBIO
$0.85
$0.000.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 33.62% | -- | 46.85% | 30.58% | -28.92% |
| Total Depreciation and Amortization | 4.27% | -- | -11.08% | -12.03% | -7.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | -94.95% | -- | -85.94% | -43.02% | 612.97% |
| Change in Net Operating Assets | 100.36% | -- | -105.83% | 42.45% | -22,380.00% |
| Cash from Operations | 4.92% | -- | 17.79% | 30.43% | 2.33% |
| Capital Expenditure | 99.52% | -- | -- | -- | 58.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -86.80% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 131.25% | -- | -- | 1,326.00% | -2,300.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 85.23% | -- | -58.88% | 69.26% | -38.28% |
| Issuance of Common Stock | -83.16% | -- | -99.56% | -99.87% | 293.81% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6,863.64% | -- | -- | -- | -- |
| Cash from Financing | -37.04% | -- | -103.80% | -106.55% | 374.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -54.84% | -- | -473.89% | -12.28% | 462.87% |